IPP Bureau

Alkem enters exclusive license agreement with Johns Hopkins University
Alkem enters exclusive license agreement with Johns Hopkins University

By IPP Bureau - January 31, 2022

The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer

Foreign Direct Investment in pharma grows at rapid pace: Eco Survey
Foreign Direct Investment in pharma grows at rapid pace: Eco Survey

By IPP Bureau - January 31, 2022

In the April-September 2021 period, the FDI inflows continued to be buoyant at Rs 4,413 crore, growing at the rate of 53 per cent over the same period in 2020-21

Union Budget 2022-23 : Industry expects increased allocation to healthcare, skill development, R&D and universal health insurance
Union Budget 2022-23 : Industry expects increased allocation to healthcare, skill development, R&D and universal health insurance

By IPP Bureau - January 30, 2022

Allocation for the healthcare sector has gone up but is still woefully short of expectations. A few leading voices from the hospital and consulting sectors share their perspective on what they expect from Budget 2022

Union Budget 2022-23 : Medtech expects incentives, GST exemptions and custom duty rationalisation
Union Budget 2022-23 : Medtech expects incentives, GST exemptions and custom duty rationalisation

By IPP Bureau - January 30, 2022

Medtech plays a vital role in the healthcare system and players in this field believe that the budget should address some of their concerns if India has to become a formidable player

DCGI approves Bharat Biotech’s Phase 3 trials for intranasal vaccine
DCGI approves Bharat Biotech’s Phase 3 trials for intranasal vaccine

By IPP Bureau - January 29, 2022

Intranasal vaccines are easier to administer in mass immunisation campaigns and help reduce or stop transmission

Union minister Mansukh Mandaviya launches NIPER website
Union minister Mansukh Mandaviya launches NIPER website

By IPP Bureau - January 29, 2022

The aim is to strengthen industry-academia cooperation

Sparsh hospital opens multi-organ transplant centre in Bengaluru
Sparsh hospital opens multi-organ transplant centre in Bengaluru

By IPP Bureau - January 29, 2022

The new centre will comprise a team of 50 highly experienced specialists

Israel signs deal to purchase Novavax’ Covid-19 vaccine
Israel signs deal to purchase Novavax’ Covid-19 vaccine

By IPP Bureau - January 29, 2022

It would be the first protein-based alternative available in Israel

ARVs bottom out while CRAMS growth continues for Laurus Labs: ICICI Direct
ARVs bottom out while CRAMS growth continues for Laurus Labs: ICICI Direct

By IPP Bureau - January 29, 2022

The management guided for ARV API & formulation demand to be normalised from Q4FY22 and reiterated the aspiration of US $ 1 billion in sales by FY23: ICICI Direct

Lonza partners with biotech firm HaemaLogiX on multiple myeloma drug candidate
Lonza partners with biotech firm HaemaLogiX on multiple myeloma drug candidate

By IPP Bureau - January 29, 2022

Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China

Lupin signs promotional agreement with Exeltis on SOLOSEC
Lupin signs promotional agreement with Exeltis on SOLOSEC

By IPP Bureau - January 28, 2022

SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment

European Commission approves Merck’s KEYTRUDA as adjuvant therapy for RCC
European Commission approves Merck’s KEYTRUDA as adjuvant therapy for RCC

By IPP Bureau - January 28, 2022

KEYTRUDA is now approved as monotherapy for adults with Renal Cell Carcinoma (RCC)

Biogen sells equity stake in its biosimilar JV with Samsung Biologics for US $ 2.3 billion
Biogen sells equity stake in its biosimilar JV with Samsung Biologics for US $ 2.3 billion

By IPP Bureau - January 28, 2022

The companies will continue with their exclusive agreements, including commercialization of their current portfolio

Moderna working on HIV vaccine antigens delivered through mRNA technology
Moderna working on HIV vaccine antigens delivered through mRNA technology

By IPP Bureau - January 28, 2022

The immunogens being tested in IAVI G002 were developed by scientific teams at IAVI and Scripps Research and will be delivered via Moderna's mRNA technology

HealthPlix is in NASSCOM’s `League of 10’ companies 2021
HealthPlix is in NASSCOM’s `League of 10’ companies 2021

By IPP Bureau - January 28, 2022

The award was given as a result of NASSCOM's meticulous screening process, in which over 700 start-ups were shortlisted as the most promising companies of the year

Latest Stories

Interviews

Packaging